Mira Pharmaceuticals (NASDAQ:MIRA) just reported results for the first quarter of 2024.
- Mira Pharmaceuticals reported earnings per share of -12 cents. This was below the analyst estimate for EPS of -10 cents.
- The company did not report any revenue for the quarter.